[{"address1": "200 Arsenal Yards Boulevard", "address2": "Suite 210", "city": "Watertown", "state": "MA", "zip": "02472", "country": "United States", "phone": "617 758 8672", "website": "https://www.sqzbiotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.", "fullTimeEmployees": 53, "companyOfficers": [{"maxAge": 1, "name": "Mr. Lawrence J. Knopf Esq.", "age": 62, "title": "General Counsel & Secretary", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": 512381, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Marshelle Smith Warren M.D.", "age": 61, "title": "Chief Medical Officer", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": 476266, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert S.  Langer Jr., Ph.D., ScD", "age": 75, "title": "Co-Founder & Member of Scientific Advisory Board", "yearBorn": 1949, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ipsita  Roymoulik Ph.D.", "title": "Senior Vice President of CMC & QUALITY", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 9, "overallRisk": 9, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1672444800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.023, "open": 0.0255, "dayLow": 0.0255, "dayHigh": 0.0255, "regularMarketPreviousClose": 0.023, "regularMarketOpen": 0.0255, "regularMarketDayLow": 0.0255, "regularMarketDayHigh": 0.0255, "payoutRatio": 0.0, "beta": 1.375, "forwardPE": -0.0011428571, "volume": 20, "regularMarketVolume": 20, "averageVolume": 1446, "averageVolume10days": 5610, "averageDailyVolume10Day": 5610, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 766769, "fiftyTwoWeekLow": 0.023, "fiftyTwoWeekHigh": 0.07, "allTimeHigh": 36.49, "allTimeLow": 0.01, "priceToSalesTrailing12Months": 0.06325955, "fiftyDayAverage": 0.02776, "twoHundredDayAverage": 0.03014, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 12031024, "profitMargins": 0.0, "floatShares": 26144472, "sharesOutstanding": 0, "sharesShort": 811150, "sharesShortPriorMonth": 743030, "sharesShortPreviousMonthDate": 1684108800, "dateShortInterest": 1686787200, "sharesPercentSharesOut": 0.0275, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.00011, "shortRatio": 27.26, "shortPercentOfFloat": 0.030299999, "impliedSharesOutstanding": 29491137, "bookValue": 0.064, "priceToBook": 0.40625, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -71643000, "trailingEps": -2.43, "forwardEps": -22.75, "enterpriseToRevenue": 0.993, "enterpriseToEbitda": -0.204, "52WeekChange": 0.13043475, "SandP52WeekChange": 0.118204355, "quoteType": "EQUITY", "currentPrice": 0.026, "recommendationKey": "none", "totalCash": 10193000, "totalCashPerShare": 0.346, "ebitda": -59061000, "totalDebt": 21472000, "quickRatio": 1.154, "currentRatio": 1.369, "totalRevenue": 12121000, "debtToEquity": 1141.52, "revenuePerShare": 0.411, "returnOnAssets": -0.41138, "returnOnEquity": -2.03372, "grossProfits": -39671000, "freeCashflow": -29514376, "operatingCashflow": -74334000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -5.01337, "financialCurrency": "USD", "symbol": "SQZB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1604064600000, "regularMarketChange": 0.0030000005, "regularMarketDayRange": "0.0255 - 0.0255", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 1446, "fiftyTwoWeekLowChange": 0.0030000005, "fiftyTwoWeekLowChangePercent": 0.13043481, "fiftyTwoWeekRange": "0.023 - 0.07", "fiftyTwoWeekHighChange": -0.044, "fiftyTwoWeekHighChangePercent": -0.62857145, "fiftyTwoWeekChangePercent": 13.043475, "earningsTimestampStart": 1749034740, "earningsTimestampEnd": 1749211200, "isEarningsDateEstimate": true, "shortName": "SQZ Biotechnologies Company", "longName": "SQZ Biotechnologies Company", "corporateActions": [], "regularMarketTime": 1760126400, "exchange": "PNK", "messageBoardId": "finmb_261457741", "exchangeTimezoneName": "America/New_York", "epsTrailingTwelveMonths": -2.43, "epsForward": -22.75, "fiftyDayAverageChange": -0.0017600004, "fiftyDayAverageChangePercent": -0.06340059, "twoHundredDayAverageChange": -0.004139999, "twoHundredDayAverageChangePercent": -0.13735896, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "marketState": "CLOSED", "regularMarketChangePercent": 13.04348, "regularMarketPrice": 0.026, "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "SQZ Biotechnologies", "trailingPegRatio": null, "__fetch_time": "2025-10-11"}]